Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non-small cell lung cancer without driver-mutations: a phase 2, single-arm trial

BACKGROUND: Non-dominant population, which means patients with advanced non-squamous lung cancer or non-small cell lung cancer (NSCLC) without driver-mutations, who are excluded from clinical studies because of specific baseline conditions refractory to multiple treatments, have poor outcomes. We as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Zhou, He, Jian-Bo, Jiang, Qinling, Xu, Linlin, Hu, Liyang, Liang, Zibin, Li, Tin, Lin, Zhong, Yu, Qitao, Pei, Xiaofeng, Lv, Weize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661875/
https://www.ncbi.nlm.nih.gov/pubmed/33209895
http://dx.doi.org/10.21037/atm-20-6539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661875/
https://www.ncbi.nlm.nih.gov/pubmed/33209895
http://dx.doi.org/10.21037/atm-20-6539

Ejemplares similares